Brady W. Dougan - Aug 18, 2025 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
Director
Signature
/s/ Brady W. Dougan by Dale A. Sander as Attorney-in-Fact
Stock symbol
HUMA
Transactions as of
Aug 18, 2025
Transactions value $
-$3,733,191
Form type
4
Date filed
8/20/2025, 07:30 PM
Previous filing
Jun 16, 2025
Next filing
Nov 17, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dougan Brady W Director 2525 EAST NORTH CAROLINA, HIGHWAY 54, DURHAM /s/ Brady W. Dougan by Dale A. Sander as Attorney-in-Fact 2025-08-20 0001878020

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUMA Common Stock Sale -$1.01M -549K -24.51% $1.83 1.69M Aug 18, 2025 By Ayabudge LLC F1, F2
transaction HUMA Common Stock Sale -$1.79M -1.1M -65.02% $1.63 592K Aug 19, 2025 By Ayabudge LLC F1, F3
transaction HUMA Common Stock Sale -$935K -592K -100% $1.58 0 Aug 20, 2025 By Ayabudge LLC F1, F4
holding HUMA Common Stock 244K Aug 18, 2025 By spouse
holding HUMA Common Stock 1.15M Aug 18, 2025 By The Niklason Living Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales were made by Ayabudge LLC, an entity controlled by Brady W. Dougan. The transactions enabled Mr. Dougan to pay down leverage while providing a mechanism for investors to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase.
F2 The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $1.79 to $1.92. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $1.57 to $1.76. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $1.53 to $1.69. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.